Biopure Corp. (BPUR) Wrap Up:

Biopure Corporation develops, manufactures, and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body’s tissues. It offers Hemopure for the treatment of adult surgical patients who are acutely anemic, as well as for eliminating, delaying, or reducing the need for red blood cell transfusions in these patients. The company also provides Oxyglobin, a veterinary product for the treatment of anemia in dogs. In addition, Biopure Corporation is developing Hemopure for a potential indication in cardiovascular ischemia and an out-of-hospital trauma indication. It has a collaboration with the U.S. Naval Medical Research Center for the de...